Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome.

Hartung HP;Strasser Fuchs S;Berger T;Vass K;Sindic C;Dubois B;Dive D;Debruyne J;Metz L;Rice G;Duquette P;Lapierre Y;Freedman M;Traboulsee A;O'Connor P;Stourac P;Taláb R;Zapletalová O;Kováøová I;Medová E;Fiedler J;Frederiksen J;Brochet B;Moreau T;Vermersch P;Pelletier J;Edan G;Clanet M;Clavelou P;Lebrun Frenay C;Gout O;Kallela M;Pirttilä T;Ruutiainen J;Koivisto K;Reunanen M;Elovaara I;Villringer A;Altenkirch H;Wessel K;Hartung HP;Steinke W;Kölmel H;Oschmann P;Diem R;Dressel A;Hoffmann F;Baum K;Jung S;Petereit HF;Reske D;Sailer M;Köhler J;Sommer N;Hohlfeld R;Henn KH;Steinbrecher A;Tumani H;Gold R;Rieckmann P;Komoly R;Gács G;Jakab G;Csiba L;Vécsei L;Miller A;Karussis D;Chapman J;Ghezzi A;Comi G;GALLO, PAOLO;Cosi V;Durelli L;Anten B;Visser L;Myhr KM;Szczudlik A;Selmaj K;Stelmasiak Z;Podemski R;Maciejek Z;Cunha L;Sega Jazbec S;Montalba X;Arbizu T;Saiz A;Bárcena J;Arroyo R;Fernández O;Izquierdo G;Casanova B;Lycke J;Kappos L;Mattle H;Beer K;Coleman R;Chataway J;O'Riordan J;Howell S. .

2012